<DOC>
	<DOC>NCT02820259</DOC>
	<brief_summary>The purpose of this study is to demonstrate that the biliary concentration of TCR is a good marker of its immunosuppressive activity.</brief_summary>
	<brief_title>Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Adult patients (&gt; 18 years) of both sexes, Candidates for liver transplantation or retransplantation, whatever the etiology and severity of the underlying disease, Not having expressed their opposition to participation in the study Bilioenteric anastomosis, Associated transplantation of another organ Contraindications to TCR administration Delayed introduction of TCR (beyond the 5th postoperative day) whatever the cause.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>